top of page
NE.jpg

IN THE STATES

NEBRASKA

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Nebraska in 2022.

NE.png

Download vendor data for Nebraska:

Economic
Output

$7.1B

Direct Jobs Supported by the Industry

4,490

Total Jobs Supported

19,358

State Total Vendor Relationships

200

State Total Vendor Spending

$106,156,647

Clinical
Trials

403

Investments at Clinical Trial Sites

$153.2M

Clinical Trial Participants

8,403

Total Economic Impact of Clinical Trial Sites

$394.7M

bottom of page